D. Bolin

Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor.

E. Goetzl, D. Bolin, M. Xia, 1997, The Journal of pharmacology and experimental therapeutics.

Structure-activity studies on the vasoactive intestinal peptide pharmacophore. 1. Analogs of tyrosine.

R. Garippa, D. Bolin, J. Michalewsky, 2009, International journal of peptide and protein research.

HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis

F. Falcioni, Z. Nagy, D. Bolin, 1996, The Journal of experimental medicine.

Solution structure of an analogue of vasoactive intestinal peptide as determined by two-dimensional NMR and circular dichroism spectroscopies and constrained molecular dynamics.

D. Fry, V. Madison, B. Wegrzynski, 1989, Biochemistry.

Influence of CD26 and integrins on the antigen sensitivity of human memory T cells.

C. Morimoto, F. Falcioni, Z. Nagy, 1996, Human immunology.